Newsroom | 38712 results

Sorted by: Latest

Other Health
-

Performant Survey Spotlights Top Healthcare Technology Initiatives

PLANTATION, Fla.--(BUSINESS WIRE)--At HIMSS25, Performant Healthcare, Inc. (Nasdaq: PHLT) (the “Company” or “Performant”), a leader in technology-enabled payment integrity, eligibility and related analytics services, conducted a targeted survey of nearly 150 healthcare technology leaders to better understand the key drivers behind healthcare technology decision-making. The findings point to a healthcare landscape increasingly shaped by innovation, efficiency and the imperative to deliver better...
-

Enhabit Home Health & Hospice Announces Date of 2025 First Quarter Earnings Call

DALLAS--(BUSINESS WIRE)--Enhabit, Inc. (NYSE: EHAB), a leading national home health and hospice provider, today announced it will report its results for the first quarter ended March 31, 2025, on May 7, 2025, and host a webcast and conference call on May 8, 2025. Individuals who would like to participate in the conference call webcast should join 15 minutes before the scheduled start time. May 8, 2025 10 a.m. EDT Toll-free: 888-660-6150 International: 929-203-0843 Conference ID: 5248158 Webcast...
-

Butterfly Network to Report First Quarter 2025 Financial Results on May 2, 2025

BURLINGTON, Mass. & NEW YORK--(BUSINESS WIRE)--Butterfly Network, Inc. (NYSE: BFLY) (“Butterfly”), a digital health company transforming care with portable, semiconductor-based ultrasound technology and intuitive software, announced that it will report first quarter 2025 financial results on May 2, 2025 before the market opens. Joseph DeVivo, President, Chief Executive Officer and Chairman of the Board, and Heather Getz, Executive Vice President and Chief Financial and Operations Officer, will...
-

Timeline, the Leading Longevity Biotech Brand, Launches First-of-Its-Kind Gummy Powered by Mitopure®

LAUSANNE, Switzerland--(BUSINESS WIRE)--Timeline®, the Swiss consumer biotech company at the forefront of longevity research, has launched Mitopure® Gummies, a new, convenient format of its Urolithin A supplement containing a patented and pure form of this powerful postbiotic. Mitopure Gummies support cellular health by helping remove damaged mitochondria and waste (a process called mitophagy) and create new, healthy mitochondria, improving the cell’s ability to produce energy, which often tran...
-

Global Sleep Symposium Features Inactivators™ Sleep Mask for Performance-Driven Sleep Support as America Faces an Unprecedented Era of Stress

ATLANTA--(BUSINESS WIRE)--As April marks National Stress Awareness Month, Atlanta-based sleep performance company The Inactive Company, is showcasing its innovative sleep mask, Inactivators™, as a science-backed solution to help combat stress by promoting deeper, restorative sleep. Developed over more than a year, largely in collaboration with hospitality and performance brands such as Equinox Hotels, the National Football League, and Collegiate Football properties, The Inactive Company is laun...
-

Komodo Health Expands Partnership With Databricks to Deliver Real-Time Access to Healthcare Data Through Delta Sharing

SAN FRANCISCO--(BUSINESS WIRE)--Komodo Health, the Evidentiary Standard for real-world data and healthcare analytics, today announced an expanded partnership with Databricks, the Data and AI company, to deliver its comprehensive, data-driven patient journey insights through the Databricks Marketplace and Delta Sharing. This collaboration leverages the Databricks Data Intelligence Platform to enhance the accessibility and scalability of Komodo's Healthcare Map® to provide unprecedented insights...
-

Trellis Health Emerges From Stealth With $1.8M Pre-Seed Funding to Provide Women With Unrivaled Access to Health Data

SAN FRANCISCO--(BUSINESS WIRE)--Trellis Health, a digital health platform designed to empower women with personalized, proactive care, today emerged from stealth. The company is launching with $1.8M in pre-seed funding from Palette Ventures, Swizzle Ventures, NEXTBLUE, Suncoast Ventures, and Sundial Foundation, along with high-profile healthcare individuals, including Care.com founder Sheila Marcelo, the co-founders of Flo Health, Yuri Gurski and Andrei Kouzel, Mike Prytkov - the founder and CE...
-

Smart Home and IoT Innovations Take Center Stage at Fiber Connect 2025

WASHINGTON--(BUSINESS WIRE)--The Fiber Broadband Association (FBA) is bringing the Smart Home and Internet of Things (IoT) to the forefront at Fiber Connect 2025, taking place June 1-4, in Nashville, Tenn. This year’s event will feature new programming designed to demonstrate why fiber is the essential infrastructure for tomorrow’s bandwidth-hungry Smart Homes. At the heart of this initiative is the Smart Home Open House, a two-day showcase dedicated to demonstrating how fiber broadband enables...
-

Thermo Fisher Scientific Opens Advanced Therapies Collaboration Center in Greater San Diego to Help Accelerate Cell Therapy Development

CARLSBAD, Calif.--(BUSINESS WIRE)--Thermo Fisher Scientific Inc., the world leader in serving science, today announced the grand opening of its Advanced Therapies Collaboration Center (ATxCC) in Carlsbad, Calif. This advanced facility is designed to accelerate the development and commercialization of cell therapies, specifically by supporting biotech, biopharma and translational customers developing cell-based immunotherapies. Through this new center, cell therapy developers can leverage Thermo...
-

Adagio Medical Holdings, Inc. Receives FDA Breakthrough Device Designation for the vCLASTM Cryoablation System

LAGUNA HILLS, Calif.--(BUSINESS WIRE)--Adagio Medical Holdings, Inc. (Nasdaq: ADGM) (“Adagio” or “the Company”), a leading innovator in catheter ablation technologies for the treatment of cardiac arrhythmias, today announced that it has received Breakthrough Device designation from the U.S. Food and Drug Administration (“FDA”) for its vCLASTM Cryoablation System for the treatment of drug-refractory, recurrent, sustained monomorphic ventricular tachycardia (“VT”) in patients with ischemic or non...